美国国家卫生研究院许可将受益于自由市场规定
概括
政府对自由市场的支持有效地推动了制药创新. 国家卫生研究院 (NIH) 可以通过将反竞争条款纳入许可协议来促进这一点,在没有新立法的情况下促进研究.
科学领域:
- 卫生政策 卫生政策
- 制药科学 制药科学
- 经济学 经济学 经济学
背景情况:
- 政府政策对制药创新有很大的影响.
- 自由市场原则经常被认为是创新的驱动力.
- 知识产权和许可在研究中的作用至关重要.
研究的目的:
- 评估政府鼓励自由市场在促进药品创新的有效性.
- 探索国家卫生研究院 (NIH) 如何利用现有的机制来支持创新.
- 确定NIH通过许可协议促进创新的策略.
主要方法:
- 分析现有政府政策及其对制药研发的影响.
- 审查NIH使用的许可协议.
- 评估"自由市场条款"及其制反竞争行为的潜力.
主要成果:
- 政府鼓励自由市场是加强制药创新的有效策略.
- 在目前的许可协议中,NIH可以实施"自由市场条款".
- 这些条款可以有效地阻止反竞争和阻碍研究的行为.
结论:
- 美国国家卫生研究院有能力通过战略许可来显著支持制药创新.
- 为了培养更具创新性的环境,不一定需要立法变化.
- 在NIH许可协议中实施特定的"自由市场条款"是一种可行的和有效的方法.
相关概念视频
Drug Nomenclature
1.7K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.7K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Standards of Care I
689
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
689
Drug Control Governance: Regulatory Bodies and Their Impact
158
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
158
